Thymus in myasthenia gravis. Isolation of T-lymphocyte lines specific for the nicotinic acetylcholine receptor from thymuses of myasthenic patients
- PMID: 2449461
- PMCID: PMC442543
- DOI: 10.1172/JCI113401
Thymus in myasthenia gravis. Isolation of T-lymphocyte lines specific for the nicotinic acetylcholine receptor from thymuses of myasthenic patients
Abstract
The thymus is believed to play a central role in the pathogenesis of Myasthenia gravis (MG). According to a previous hypothesis, MG is initiated within the thymus by immunogenic presentation of locally produced nicotinic acetylcholine receptor (AChR) to potentially autoimmune T cells. Data of 10 consecutive MG patients demonstrate two critical features of MG thymuses that support the concept of intrathymic activation of autoreactive, AChR-specific lymphocytes. Morphologically, the thymuses showed lympho-follicular hyperplasia in nine cases and benign thymoma in one case. The paramount feature revealed by immunohistological double marker analyses was the intimate association of myoid cells (antigen producing) with interdigitating reticulum cells (potentially antigen presenting cells), both of which were surrounded by T3+ lymphocytes in thymus medulla. All 10 thymuses contained T lymphocytes reactive with AChR. This was in contrast to the peripheral immune compartment (blood) where in only 3 of 10 patients, significant T cell responses to AChR were observed. AChR-specific T cell lines could be established from 8 of 10 thymuses, all members of the helper/inducer subset as indicated by the expression of markers T3 and T4.
Similar articles
-
T-helper epitopes on human nicotinic acetylcholine receptor in myasthenia gravis.Ann N Y Acad Sci. 1993 Jun 21;681:198-218. doi: 10.1111/j.1749-6632.1993.tb22887.x. Ann N Y Acad Sci. 1993. PMID: 7689306
-
Nicotinic acetylcholine receptor mRNAs in myasthenic thymuses: association with intrathymic pathogenesis of myasthenia gravis.Biochem Biophys Res Commun. 1993 Aug 16;194(3):1269-75. doi: 10.1006/bbrc.1993.1960. Biochem Biophys Res Commun. 1993. PMID: 8352784
-
Pathogenesis of myasthenia gravis. Acetylcholine receptor-related antigenic determinants in tumor-free thymuses and thymic epithelial tumors.Am J Pathol. 1988 Feb;130(2):268-80. Am J Pathol. 1988. PMID: 2449082 Free PMC article.
-
The role of the thymus in myasthenia gravis.Adv Neuroimmunol. 1994;4(4):373-86. doi: 10.1016/0960-5428(94)00040-u. Adv Neuroimmunol. 1994. PMID: 7536601 Review.
-
Myasthenia gravis.Verh Dtsch Ges Pathol. 1996;80:116-26. Verh Dtsch Ges Pathol. 1996. PMID: 9020569 Review.
Cited by
-
Oral administration of a dual analog of two myasthenogenic T cell epitopes down-regulates experimental autoimmune myasthenia gravis in mice.Proc Natl Acad Sci U S A. 2000 Feb 29;97(5):2168-73. doi: 10.1073/pnas.040554597. Proc Natl Acad Sci U S A. 2000. PMID: 10681457 Free PMC article.
-
Novel CXCL13 transgenic mouse: inflammation drives pathogenic effect of CXCL13 in experimental myasthenia gravis.Oncotarget. 2016 Feb 16;7(7):7550-62. doi: 10.18632/oncotarget.6885. Oncotarget. 2016. PMID: 26771137 Free PMC article.
-
Schwann cells and myasthenia gravis. Preferential uptake of soluble and membrane-bound AChR by normal and immortalized Schwann cells, and immunogenic presentation to AChR-specific T line lymphocytes.Am J Pathol. 1990 Jan;136(1):111-22. Am J Pathol. 1990. PMID: 1688688 Free PMC article.
-
Circulating regulatory anti-T cell receptor antibodies in patients with myasthenia gravis.J Clin Invest. 2003 Jul;112(2):265-74. doi: 10.1172/JCI16039. J Clin Invest. 2003. PMID: 12865414 Free PMC article.
-
Intrathymic expression of neuromuscular acetylcholine receptors and the immunpathogenesis of myasthenia gravis.Immunol Res. 2003;27(2-3):399-408. doi: 10.1385/IR:27:2-3:399. Immunol Res. 2003. PMID: 12857984 Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical